Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Silylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101535274A details a cost-effective synthesis route for difluoromethyl pyrazole intermediates, offering significant supply chain advantages for agrochemical manufacturers.
Novel Rh-catalyzed hydrosilylation patent CN108586512A offers high yield Z-beta vinyl silanes. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediate manufacturing.
Novel patent CN106831756B offers high-yield Aclidinium Bromide synthesis. Reduces costs and ensures supply chain stability for COPD pharmaceutical manufacturing.
Patent CN106083908A reveals cobalt-catalyzed hydrosilylation enabling high-purity alkenyl silanes with significant cost reduction in pharma intermediates manufacturing.
Patent CN104478919B details iron-catalyzed chiral silane synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN110229180B reveals air-tolerant manganese catalysis for selective alkenyl silane production, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN111925282A reveals mild catalytic reduction for high-purity pharmaceutical intermediates. Enhances supply chain safety and reduces manufacturing costs significantly.
Patent CN109503645A reveals cobalt-catalyzed asymmetric hydrosilylation for high-purity chiral gem-disilanes, offering cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN120230062A details a novel copper-catalyzed route for (R)-4-propyl-dihydrofuran-2-one, offering improved yield and supply chain reliability for pharmaceutical manufacturers.
Patent CN116284100A details a Cu-catalyzed decarboxylative silylation. Offers high E-selectivity and cost efficiency for pharma intermediates.
Patent CN107235875A reveals mild fluoride-catalyzed route for fluorinated monomers. Delivers high yield and supply chain stability for polymer material manufacturing.
Patent CN111995636A details a novel Ru-catalyzed hydrosilylation route for ortho-hydroxy-nitrogen silanes, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN118771989A reveals a novel manganese catalyst for amide reduction. This technology offers cost-effective, scalable solutions for high-purity pharmaceutical intermediate manufacturing.
Patent CN102153432B reveals a metal-free cascade synthesis for alpha-trifluoromethyl-gamma-carbonyl esters, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109651421A details a ruthenium-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN107235995B details a cobalt-catalyzed asymmetric hydrosilylation method offering high enantioselectivity and cost reduction in organosilicon manufacturing for global supply chains.
Patent CN109705154B details a cobalt-catalyzed tandem hydrosilylation for synthesizing exo-gem-disilyl alkanes. This method offers superior regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111187292B details a heterogeneous cobalt-catalyzed hydrosilylation method offering high regioselectivity for alpha-vinyl silanes, ensuring cost-effective supply chain solutions.
Patent CN114315906B discloses novel chiral phosphite ligands enabling high-yield asymmetric hydrosilylation and hydroformylation for reliable pharmaceutical intermediate supplier networks.
Patent CN112778351B details a ligand-free, green synthesis of beta-dimethylphenyl silicon substituted aromatic nitro compounds using recyclable cellulose-supported copper nanoparticles.